Comparative activity in vitro of ceftazidime and nine other antibacterial agents D. S. ReevesH. A. HoltM. J. Bywater OriginalPaper Pages: S3 - S11
The current state of cephalosporin antibiotics: Microbiological aspects H. KnotheG. A. Dette OriginalPaper Pages: S12 - S15
The in vitro activity of ceftazidime against a multi-resistant serotype 12 Pseudomonas aeruginosa G. NinaneP. B. Harper OriginalPaper Pages: S16 - S19
In vitro activity of new cephalosporins against multi-resistant gramnegative bacteria V. FainsteinBarbara Le BlancG. P. Bodey OriginalPaper Pages: S20 - S22
The in vitro activity of ceftazidime against resistant clinical isolates H. W. Van LanduytB. L. L. DenolfAnnemie M. Lambert OriginalPaper Pages: S23 - S27
The distribution of Klebsiella pneumoniae serotypes from different sources and their sensitivity to cephalosporins U. Ullmann OriginalPaper Pages: S28 - S31
In vitro activity of ceftazidime (GR 20263) and other β-lactam antibiotics against Haemophilus influenzae P. PiotE. Van DyckJ. Colaert OriginalPaper Pages: S32 - S34
Criteria for the assessment of susceptibility to ceftazidime using the disc diffusion procedure H. Grimm OriginalPaper Pages: S35 - S38
Inactivation of cephalosporins by beta-lactamases of gram-negative rods A. BauernfeindCh. PetermüllerR. Jungwirth OriginalPaper Pages: S39 - S43
The pharmacokinetic behaviour of ceftazidime in man and the relationship between serum levels and the in vitro susceptibility of clinical isolates S. M. HardingP. B. Harper OriginalPaper Pages: S49 - S53
Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats R. MarreD. HerhahnK. Sack OriginalPaper Pages: S54 - S56
Assessment of the nephrotoxic potential of ceftazidime and a ceftazidime/tobramycin combination in volunteers A. W. MondorfF. T. HeynoldW. Schoeppe OriginalPaper Pages: S57 - S62
